Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hart

Showing results (571-580 of 590) with videos related to

Pageof 59
Sort By:
Leukemia|June 22, 2011
SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignanciesS Hart, K C Goh, V Novotny-Diermayr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastomaJulieann Rader, Mike R Russell, Lori S Hart, et al.
Science Translational Medicine|July 2, 2025
Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the CongoTakara Nishiyama, Fuminari Miura, Yong Dam Jeong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Novel agents in the treatment of lung cancer: Fourth Cambridge ConferenceThomas J Lynch, Philip D Bonomi, Charles Butts, et al.
Cancer Research|June 8, 2011
Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1Patrick A Mayes, Nathan G Dolloff, Colin J Daniel, et al.
The Journal of Clinical Investigation|February 27, 2014
Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanomaXiao-Hong Ma, Sheng-Fu Piao, Souvik Dey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Dual <i>ALK</i> and <i>CDK4/6</i> Inhibition Demonstrates Synergy against NeuroblastomaAndrew C Wood, Kateryna Krytska, Hannah T Ryles, et al.
The Journal of Experimental Biology|July 22, 2025
Emerging frontiers in visual ecologyEleanor M Caves, Karen L Cheney, Marie Dacke, et al.
Neurology|June 13, 2024
Validation of the 2023 International Diagnostic Criteria for MOGAD in a Selected Cohort of Adults and ChildrenJames A Varley, Dimitrios Champsas, Timothy Prossor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agentsThomas J Lynch, Alex A Adjei, Paul A Bunn, et al.
Pageof 59

Showing results (571-580 of 590) with videos related to

Sort By:
Pageof 59
Leukemia|June 22, 2011
SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignanciesS Hart, K C Goh, V Novotny-Diermayr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastomaJulieann Rader, Mike R Russell, Lori S Hart, et al.
Science Translational Medicine|July 2, 2025
Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the CongoTakara Nishiyama, Fuminari Miura, Yong Dam Jeong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Novel agents in the treatment of lung cancer: Fourth Cambridge ConferenceThomas J Lynch, Philip D Bonomi, Charles Butts, et al.
Cancer Research|June 8, 2011
Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1Patrick A Mayes, Nathan G Dolloff, Colin J Daniel, et al.
The Journal of Clinical Investigation|February 27, 2014
Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanomaXiao-Hong Ma, Sheng-Fu Piao, Souvik Dey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Dual <i>ALK</i> and <i>CDK4/6</i> Inhibition Demonstrates Synergy against NeuroblastomaAndrew C Wood, Kateryna Krytska, Hannah T Ryles, et al.
The Journal of Experimental Biology|July 22, 2025
Emerging frontiers in visual ecologyEleanor M Caves, Karen L Cheney, Marie Dacke, et al.
Neurology|June 13, 2024
Validation of the 2023 International Diagnostic Criteria for MOGAD in a Selected Cohort of Adults and ChildrenJames A Varley, Dimitrios Champsas, Timothy Prossor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agentsThomas J Lynch, Alex A Adjei, Paul A Bunn, et al.
Pageof 59